In trading today, Aptose Biosciences Inc shares closed at $2.11 after opening the day at $2.33. Intraday prices ranged from $2.10 to $2.33.

Share prices dipped -5.80 percent from the previous day's close of $2.24.

Today across North America, the TSX Composite closed 0.27% at 22167.03, the S&P 500 closed 0.11% at 5254.35, the Dow Jones Industrial Average closed 0.12% at 39807.37 and the Nasdaq Composite closed -0.12% at 16379.46.

Aptose Biosciences Inc traded under APS on the Toronto Stock Exchange (TSX).

Trading volume was 12,332 on 82 total trades. On average, Aptose Biosciences Inc has traded 5,656 shares in the last five days and 6,135 year-to-date.

Trading across the entire TSX saw 1,761 price advancers against 3,499 declines and 110 unchanged.

During the prior 52 weeks, APS.TO has traded as high as $12.90 (April 03,2023) and low as $1.85 (March 14,2024). Moreover, the shares have shrunken -83.83 percent in the last year, while they have shrunken -37.01% since the start of 2024.

Following today's trading, Aptose Biosciences Inc has a market capitalization of $35.18 million on a float of 15,718 shares outstanding. Its annual EPS is $-7.58.

Aptose Biosciences Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Aptose Biosciences Inc's consensus rating is "Strong Buy" based on 3 analysts according to Zacks. From those 3 analysts, 3 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..